Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

Multidrug-resistant and extensively drug-resistant tuberculosis (TB) are associated with worse treatment outcomes for patients, including higher mortality, than for drug-sensitive tuberculosis. Delamanid (OPC-67683) is a novel anti-TB medication with demonstrated activity against multidrug-resistant...

Descripción completa

Detalles Bibliográficos
Autores principales: Skripconoka, Vija, Danilovits, Manfred, Pehme, Lea, Tomson, Tarmo, Skenders, Girts, Kummik, Tiina, Cirule, Andra, Leimane, Vaira, Kurve, Anu, Levina, Klavdia, Geiter, Lawrence J., Manissero, Davide, Wells, Charles D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669462/
https://www.ncbi.nlm.nih.gov/pubmed/23018916
http://dx.doi.org/10.1183/09031936.00125812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669462/
https://www.ncbi.nlm.nih.gov/pubmed/23018916
http://dx.doi.org/10.1183/09031936.00125812

Ejemplares similares